| Huang, Wenrong |
NCT05050630: Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL |
|
|
| Recruiting | 2 | 73 | RoW | TR2-ICE | Affiliated Hospital to Academy of Military Medical Sciences, Beijing Cancer Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Age Range ≥16 Years, Gender Unlimited, Histopathology Confirmed Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma, Received Prior First-line Chemotherapy for DLBCL or HGBL, Failed to Reach CR for Four Cycles, or Relapsed, At Least One Positive Lesion According to the 2014 Lugano Criteria for Hodgkin's and Non-Hodgkin's Lymphoma, ECOG Physical Status Score is 0-3, The Researchers Judged That Life Expectancy Was at Least Three Months, Understand and Voluntarily Sign Written Informed Consent | 07/22 | 07/23 | | |
NCT04324879: A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL) |
|
|
| Recruiting | 2 | 80 | RoW | TQ-B3525 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Relapsed / Refractory Follicular Lymphoma | 12/22 | 12/22 | | |
RMO, NCT05549284: Orelabrutinib,Rituximab and Methotrexate in Newly-diagnosed Primary Central Nervous System Lymphoma(PCNSL) |
|
|
| Recruiting | 2 | 36 | RoW | Orelabrutinib,Rituximab and Methotrexate, RMO | Affiliated Hospital to Academy of Military Medical Sciences | Primary Central Nervous System Lymphoma | 05/23 | 05/26 | | |
NCT05517213: High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma |
|
|
| Recruiting | N/A | 164 | RoW | Etoposide, VP-16, Cyclophosphamide, CTX | Affiliated Hospital to Academy of Military Medical Sciences | Multiple Myeloma | 10/24 | 10/25 | | |
NCT05282095: Effect of HPV Integration on Prognosis of Young Women With CIN2 in China |
|
|
| Recruiting | N/A | 300 | RoW | Follow up | Fujian Maternity and Child Health Hospital | Cervical Intraepithelial Neoplasia, HPV Infection, Virus Integration, HSIL, High Grade Squamous Intraepithelial Lesions | 12/25 | 05/26 | | |
